Blog

Oct 27, 2023

Acme United Recalls PhysiciansCare Brand Allergy Relief and Cold and Cough Tablets Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning; Sold on Amazon.com

The recalled products contain diphenhydramine hydrochloride and acetaminophen

The recalled products contain diphenhydramine hydrochloride and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

About 2,400

Acme United toll-free at 888-803-0509 from 8 a.m. to 5 p.m. ET Monday through Friday, or online at https://www.recallrtr.com/acmeunitedotc2 or at www.acmeunited.com and click on "Recalls" at the bottom of the page for more information.

This recall involves PhysiciansCare brand Allergy caplets with item number 90036, Allergy Plus tablets with item number 90091, and Cold and Cough tablets with item numbers 90092 and 90033. They are packaged in boxes of 50, 100 and 250 tablets/caplets. The item numbers are printed on the top right corner of the box.

The recall includes the following:

Item Number

Description

90036

PhysiciansCare Allergy; 50 caplets

90091

PhysiciansCare Allergy Plus; 100 tablets

90092

PhysiciansCare Non-Drowsy Cold and Cough; 100 tablets

90033

PhysiciansCare Cold and Cough; 250 tablets

Consumers should immediately store the recalled products in a safe location out of reach of children and contact Acme United for information on how to dispose of the products and receive a refund of Acme United's average selling price of between $5 and $19.

None reported

Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.

The whiteboard attached to the boxes can become detached exposing sharp edges, posing a laceration hazard.

The recalled products contain diphenhydramine hydrochloride and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

The recalled headlight sealant contains low-viscosity hydrocarbons which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging for the products does not meet federal child resistant packaging requirements, posing a risk of poisoning if the contents are swallowed by young children.

The product contains low-viscosity petroleum distillates which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant. Petroleum distillates can get into the lungs causing chemical pneumonia and/or pulmonary damage which can be fatal. In addition, the label on the products violates the Federal Hazardous Substance Act (FHSA) by omitting mandatory information on the packaging.

Pieces of glass can be found in some of the recalled jars, posing a laceration hazard to consumers.

The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.